← Back to ODTX

Odyssey Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026
$0$0$1$1.9
−$53−$38−$41−$38
−$1.74−$6.77−$29.54−$39.37
305.71.41

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.